retatrutide type 2 diabetes phase 2 results 2024 2025 Updates in Medicine | Pharmacologic Management of – ADA 🔗 Original article link in bio 🧠 Stepwise approach based on comorbidities and Retatrutide UK Guide: Key Facts

For the regulatory status question alone, see our retatrutide FDA approval status page

Of these patients, 90,210 (5.2%) had a diagnosis of PCOS

This site is for educational purposes only and is not medical advice

Please refer to our Shipping & Returns policy for full details

If you are prescribed through our telehealth partner, please submit a new online consultation for a refill

Frias JP, Deenadayalan S, Erichsen L (2023) Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial